Verve Therapeutics Inc
NASDAQ:VERV

Watchlist Manager
Verve Therapeutics Inc Logo
Verve Therapeutics Inc
NASDAQ:VERV
Watchlist
Price: 11.13 USD
Market Cap: 992.1m USD

Wall Street
Price Targets

VERV Price Targets Summary
Verve Therapeutics Inc

There are no price targets for VERV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Verve Therapeutics Inc Competitors:
Price Targets
ABNX
Abionyx Pharma SA
218% Upside
206650
EuBiologics Co Ltd
58% Upside
ALEC
Alector Inc
49% Upside
RCUS
Arcus Biosciences Inc
60% Upside
AVCT
Avacta Group PLC
4% Upside
VCYT
Veracyte Inc
14% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
33% Upside
APLS
Apellis Pharmaceuticals Inc
43% Upside

Revenue
Forecast

Revenue Estimate
Verve Therapeutics Inc

The compound annual growth rate of Verve Therapeutics Inc's revenue for the next 3 years is -18%.

N/A
Past Growth
-18%
Estimated Growth
Estimates Accuracy
51%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Verve Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Verve Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VERV's stock price target?
Not Available

VERV doesn't have any price targets made by Wall Street professionals.

What is Verve Therapeutics Inc's Revenue forecast?
Projected CAGR
-18%

The compound annual growth rate of Verve Therapeutics Inc's revenue for the next 3 years is -18%.

Back to Top